- INTRODUCTION TO ANXIETY AND FEAR-RELATED DISORDERS
- HISTORICAL PERSPECTIVES: FROM “NERVOUS DISORDERS” TO DSM-5-TR
- DIAGNOSTIC CRITERIA AND ICD-11 CROSSWALK
- THE NATURE OF FEAR VS. ANXIETY
- DISTINGUISHING NORMAL ANXIETY FROM PATHOLOGICAL ANXIETY
- DEVELOPMENTAL PATHWAYS OF ANXIETY DISORDERS
- CULTURAL CONCEPTS OF FEAR AND ANXIETY
- EPIDEMIOLOGY AND GLOBAL BURDEN
- STIGMA AND SOCIAL PERCEPTIONS OF ANXIETY
- THE STRESS RESPONSE AND ITS ROLE IN ANXIETY
- AMYGDALA AND LIMBIC SYSTEM IN FEAR PROCESSING
- HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN ANXIETY
- NEUROTRANSMITTER SYSTEMS: GABA, SEROTONIN, NOREPINEPHRINE
- NEURAL CIRCUITRY OF PANIC AND PHOBIC REACTIONS
- BRAIN IMAGING FINDINGS IN ANXIETY DISORDERS
- GENETICS AND HERITABILITY OF ANXIETY
- EPIGENETIC MODIFICATIONS IN STRESS AND FEAR
- NEURODEVELOPMENTAL INFLUENCES ON ANXIETY RISK
- ROLE OF NEUROINFLAMMATION AND IMMUNE SIGNALING
- GUT–BRAIN AXIS AND MICROBIOME IN ANXIETY
- GAD: CLINICAL FEATURES AND DIAGNOSTIC CRITERIA
- COGNITIVE PATTERNS AND WORRY MECHANISMS
- GAD ACROSS THE LIFESPAN: CHILDREN TO OLDER ADULTS
- SLEEP DISTURBANCES IN GAD
- SOMATIC SYMPTOMS AND MEDICAL OVERLAP
- COGNITIVE MODELS OF CHRONIC WORRY
- RISK FACTORS AND COURSE OF GAD
- DISTINGUISHING GAD FROM NORMAL WORRY
- COMORBIDITY OF GAD WITH DEPRESSION
- EVIDENCE-BASED TREATMENT MODELS FOR GAD (THEORY ONLY)
- PATHOPHYSIOLOGY OF PANIC ATTACKS
- INTEROCEPTIVE CONDITIONING AND PANIC
- GENETIC AND ENVIRONMENTAL RISK FACTORS
- PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA
- DIFFERENTIATING PANIC ATTACKS FROM MEDICAL EVENTS
- CHRONIC COURSE AND RELAPSE RISK IN PANIC DISORDER
- CULTURAL EXPRESSIONS OF PANIC SYMPTOMS
- COGNITIVE-BEHAVIORAL MODELS OF PANIC
- PHARMACOLOGIC MECHANISMS IN PANIC DISORDER
- THE ROLE OF HYPERVENTILATION AND CARBON DIOXIDE SENSITIVITY
- SPECIFIC PHOBIAS: TYPES AND DIAGNOSTIC CRITERIA
- BLOOD-INJECTION-INJURY PHOBIA: VASOVAGAL MECHANISMS
- ANIMAL-TYPE AND NATURAL ENVIRONMENT PHOBIAS
- SITUATIONAL PHOBIAS: FLYING, HEIGHTS, AND CLAUSTROPHOBIA
- DEVELOPMENTAL ORIGINS OF PHOBIC DISORDERS
- EVOLUTIONARY PERSPECTIVES ON PHOBIAS
- COGNITIVE AND BEHAVIORAL THEORIES OF PHOBIA ACQUISITION
- CULTURAL VARIATIONS IN PHOBIA PREVALENCE
- VIRTUAL REALITY AND PHOBIA RESEARCH (CONCEPTUAL)
- NEURAL BASIS OF FEAR EXTINCTION
- SOCIAL ANXIETY DISORDER: CLINICAL PROFILE AND COURSE
- COGNITIVE MODELS OF SOCIAL FEAR AND SELF-CONSCIOUSNESS
- ROLE OF SHAME AND SELF-CRITICISM
- NEUROIMAGING OF SOCIAL THREAT PERCEPTION
- SOCIAL ANXIETY IN ADOLESCENCE
- PUBLIC SPEAKING ANXIETY AS A SPECTRUM
- INTERNET AND SOCIAL MEDIA EFFECTS ON SOCIAL ANXIETY
- CROSS-CULTURAL VIEWS ON SOCIAL ANXIETY
- SELECTIVE MUTISM: DEVELOPMENTAL AND FAMILY FACTORS
- OVERLAP OF SOCIAL ANXIETY AND AUTISM SPECTRUM TRAITS
- SEPARATION ANXIETY DISORDER: DEVELOPMENTAL PATHWAYS
- DIFFERENTIAL DIAGNOSIS: SEPARATION ANXIETY VS. SCHOOL REFUSAL
- FAMILY DYNAMICS AND ATTACHMENT PATTERNS
- GENETIC AND ENVIRONMENTAL RISKS IN PEDIATRIC ANXIETY
- LONG-TERM OUTCOMES OF UNTREATED CHILDHOOD ANXIETY
- PARENT–CHILD INTERACTION MODELS
- CULTURAL NORMS IN CHILDHOOD INDEPENDENCE AND ANXIETY
- EARLY PREVENTION AND SCHOOL-BASED PROGRAMS (THEORY)
- PEDIATRIC ANXIETY AND SLEEP DISORDERS
- ADOLESCENT HORMONAL INFLUENCES ON ANXIETY
- MECHANISMS OF SSRIS AND SNRIS IN ANXIETY DISORDERS
- BENZODIAZEPINES: MECHANISMS AND RISKS
- BUSPIRONE AND NOVEL ANXIOLYTICS
- ROLE OF BETA-BLOCKERS IN PERFORMANCE ANXIETY
- PHARMACOGENOMICS OF ANXIOLYTIC RESPONSE
- EMERGING AGENTS: NEUROPEPTIDE AND GLUTAMATE TARGETS
- LONG-TERM NEUROADAPTATIONS TO ANXIOLYTICS
- RISK–BENEFIT ANALYSIS OF CHRONIC PHARMACOTHERAPY
- WITHDRAWAL AND DISCONTINUATION CONCEPTS
- FUTURE DIRECTIONS IN PHARMACOLOGIC TREATMENT
- COGNITIVE BEHAVIORAL THEORY FOR ANXIETY DISORDERS
- EXPOSURE THERAPY: MECHANISMS AND THEORY
- ACCEPTANCE AND COMMITMENT THEORY FOR ANXIETY
- MINDFULNESS-BASED APPROACHES
- METACOGNITIVE MODELS OF WORRY AND RUMINATION
- EMOTION REGULATION AND DISTRESS TOLERANCE SKILLS
- GROUP PSYCHOEDUCATION PRINCIPLES
- FAMILY-BASED INTERVENTIONS (CONCEPTUAL FRAMEWORK)
- DIGITAL AND APP-BASED ANXIETY INTERVENTIONS
- SOCIAL PRESCRIBING AND COMMUNITY SUPPORTS
- PREDICTIVE BIOMARKERS AND MACHINE LEARNING IN ANXIETY
- LONGITUDINAL COHORT STUDIES ON ANXIETY DEVELOPMENT
- CLIMATE CHANGE AND ECO-ANXIETY
- ANXIETY DISORDERS IN CONFLICT AND DISASTER ZONES
- OCCUPATIONAL AND WORKPLACE ANXIETY: POLICY SOLUTIONS
- SCHOOL AND UNIVERSITY MENTAL HEALTH PROGRAMS
- REDUCING STIGMA THROUGH MEDIA AND EDUCATION
- INTEGRATING PRIMARY CARE AND ANXIETY MANAGEMENT
- ETHICAL ISSUES IN EARLY GENETIC SCREENING FOR ANXIETY
- GLOBAL MENTAL HEALTH STRATEGIES FOR ANXIETY DISORDERS